Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICUCW) Return on Sales (2023 - 2025)

SeaStar Medical Holding's Return on Sales history spans 3 years, with the latest figure at 7.52% for Q4 2025.

  • For Q4 2025, Return on Sales rose 5843.0% year-over-year to 7.52%; the TTM value through Dec 2025 reached 10.12%, up 17380.0%, while the annual FY2025 figure was 10.12%, 17380.0% up from the prior year.
  • Return on Sales reached 7.52% in Q4 2025 per ICUCW's latest filing, up from 18.97% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 141.48% in Q1 2024 to a low of 65.96% in Q4 2024.
  • Average Return on Sales over 3 years is 3.15%, with a median of 6.72% recorded in 2025.
  • Peak YoY movement for Return on Sales: surged 12509bps in 2024, then tumbled -15435bps in 2025.
  • A 3-year view of Return on Sales shows it stood at 39.87% in 2023, then tumbled by -265bps to 65.96% in 2024, then soared by 89bps to 7.52% in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Return on Sales are 7.52% (Q4 2025), 18.97% (Q3 2025), and 5.92% (Q2 2025).